196 related articles for article (PubMed ID: 25091705)
1. Solubility and some crystallization properties of conglomerate forming chiral drug guaifenesin in water.
Fayzullin RR; Lorenz H; Bredikhina ZA; Bredikhin AA; Seidel-Morgenstern A
J Pharm Sci; 2014 Oct; 103(10):3176-82. PubMed ID: 25091705
[TBL] [Abstract][Full Text] [Related]
2. Solubility, metastable zone width, and racemic characterization of propranolol hydrochloride.
Wang X; Wang XJ; Ching CB
Chirality; 2002 May; 14(4):318-24. PubMed ID: 11968072
[TBL] [Abstract][Full Text] [Related]
3. Crystal growth formation in melt extrudates.
Bruce C; Fegely KA; Rajabi-Siahboomi AR; McGinity JW
Int J Pharm; 2007 Aug; 341(1-2):162-72. PubMed ID: 17524578
[TBL] [Abstract][Full Text] [Related]
4. Anion effect on the binary and ternary phase diagrams of chiral medetomidine salts and conglomerate crystal formation.
Choobdari E; Fakhraian H; Peyrovi MH
Chirality; 2014 Mar; 26(3):183-8. PubMed ID: 24574075
[TBL] [Abstract][Full Text] [Related]
5. Enantiomeric 3-chloromandelic acid system: binary melting point phase diagram, ternary solubility phase diagrams and polymorphism.
Le Minh T; von Langermann J; Lorenz H; Seidel-Morgenstern A
J Pharm Sci; 2010 Sep; 99(9):4084-95. PubMed ID: 20575001
[TBL] [Abstract][Full Text] [Related]
6. Solid-Phase and Oscillating Solution Crystallization Behavior of (+)- and (-)-N-Methylephedrine.
Tulashie SK; Polenske D; Seidel-Morgenstern A; Lorenz H
J Pharm Sci; 2016 Nov; 105(11):3359-3365. PubMed ID: 27659160
[TBL] [Abstract][Full Text] [Related]
7. Impact of molecular flexibility on double polymorphism, solid solutions and chiral discrimination during crystallization of diprophylline enantiomers.
Brandel C; Amharar Y; Rollinger JM; Griesser UJ; Cartigny Y; Petit S; Coquerel G
Mol Pharm; 2013 Oct; 10(10):3850-61. PubMed ID: 23984951
[TBL] [Abstract][Full Text] [Related]
8. Solubility of guaifenesin in the presence of common pharmaceutical additives.
Mani N; Jun HW; Beach JW; Nerurkar J
Pharm Dev Technol; 2003; 8(4):385-96. PubMed ID: 14601963
[TBL] [Abstract][Full Text] [Related]
9. Study of the characterization and crystallization of 4-hydroxy-2-pyrrolidone.
Wang XJ; Wiehler H; Ching CB
Chirality; 2004 May; 16(4):220-7. PubMed ID: 15034904
[TBL] [Abstract][Full Text] [Related]
10. Application of preferential crystallization to resolve racemic compounds in a hybrid process.
Lorenz H; Polenske D; Seidel-Morgenstern A
Chirality; 2006 Nov; 18(10):828-40. PubMed ID: 16917833
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of preferential enrichment, an unusual enantiomeric resolution phenomenon caused by polymorphic transition during crystallization of mixed crystals composed of two enantiomers.
Tamura R; Fujimoto D; Lepp Z; Misaki K; Miura H; Takahashi H; Ushio T; Nakai T; Hirotsu K
J Am Chem Soc; 2002 Nov; 124(44):13139-53. PubMed ID: 12405843
[TBL] [Abstract][Full Text] [Related]
12. Aqueous film coating to reduce recrystallization of guaifenesin from hot-melt extruded acrylic matrices.
Bruce CD; Fegely KA; Rajabi-Siahboomi AR; McGinity JW
Drug Dev Ind Pharm; 2010 Feb; 36(2):218-26. PubMed ID: 19877992
[TBL] [Abstract][Full Text] [Related]
13. Enabling Direct Preferential Crystallization in a Stable Racemic Compound System.
Harfouche LC; Brandel C; Cartigny Y; Ter Horst JH; Coquerel G; Petit S
Mol Pharm; 2019 Nov; 16(11):4670-4676. PubMed ID: 31545612
[TBL] [Abstract][Full Text] [Related]
14. Investigation of the Binary System of Proxyphylline Enantiomers: Structural Resolution and Phase Diagram Determination.
Pinetre C; Harfouche L; Brandel C; Bendeif EE; Sanselme M; Cartigny Y; Couvrat N; Dupray V
Mol Pharm; 2024 Feb; 21(2):845-853. PubMed ID: 38134443
[TBL] [Abstract][Full Text] [Related]
15. Physicochemical properties, binary and ternary phase diagrams of ketoprofen.
Hong Lu Y; Bun Ching C
Chirality; 2004 Oct; 16(8):541-8. PubMed ID: 15290690
[TBL] [Abstract][Full Text] [Related]
16. Discovery of a solid solution of enantiomers in a racemate-forming system by seeding.
Huang J; Chen S; Guzei IA; Yu L
J Am Chem Soc; 2006 Sep; 128(36):11985-92. PubMed ID: 16953640
[TBL] [Abstract][Full Text] [Related]
17. Investigation of the phase diagrams of chiral praziquantel.
Liu Y; Wang X; Wang JK; Ching CB
Chirality; 2006 May; 18(4):259-64. PubMed ID: 16521119
[TBL] [Abstract][Full Text] [Related]
18. The influence of guaifenesin and ketoprofen on the properties of hot-melt extruded polyethylene oxide films.
Crowley MM; Fredersdorf A; Schroeder B; Kucera S; Prodduturi S; Repka MA; McGinity JW
Eur J Pharm Sci; 2004 Aug; 22(5):409-18. PubMed ID: 15265510
[TBL] [Abstract][Full Text] [Related]
19. The influence of heterogeneous nucleation on the surface crystallization of guaifenesin from melt extrudates containing Eudragit L10055 or Acryl-EZE.
Bruce CD; Fegely KA; Rajabi-Siahboomi AR; McGinity JW
Eur J Pharm Biopharm; 2010 May; 75(1):71-8. PubMed ID: 19995604
[TBL] [Abstract][Full Text] [Related]
20. Novel stereoselective high-performance liquid chromatographic method for simultaneous determination of guaifenesin and ketorolac enantiomers in human plasma.
Maher HM; Al-Taweel SM; Alshehri MM; Alzoman NZ
Chirality; 2014 Oct; 26(10):629-39. PubMed ID: 25043279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
